XOMA Royalty (XOMA) Payables (2010 - 2026)
XOMA Royalty's (XOMA) quarterly Payables came in at $3.5 million in Q1 2026, up 52.39% year-on-year from $2.3 million in Q1 2025, and up 60.05% quarter-over-quarter from $2.2 million in Q4 2025.
XOMA Royalty (XOMA) Payables (2010 - 2026) Analysis & Trends
XOMA Royalty has disclosed Payables across 17 years of filings, most recently posting $3.5 million for Q1 2026.
- Payables for Q1 2026 came in at $3.5 million, up 52.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 52.39% YoY), and the FY2025 annual result was $2.2 million, up 109.69% from the prior year.
- Payables came in at $3.5 million for Q1 2026 at XOMA Royalty, up from $2.2 million in the prior quarter.
- In the past five years, Payables ranged from a high of $3.5 million in Q1 2026 to a low of $437000.0 in Q1 2023.
- The 5-year median for Payables is $1.1 million (2024), against an average of $1.3 million.
- Across the five-year window, Payables sank 51.12% in 2022 and jumped 246.68% in 2024, its largest moves.
- XOMA Royalty's Payables stood at $524000.0 in 2022, then climbed by 24.62% to $653000.0 in 2023, then jumped by 61.26% to $1.1 million in 2024, then surged by 109.69% to $2.2 million in 2025, then jumped by 60.05% to $3.5 million in 2026.
- The last three Payables figures came in at $3.5 million (Q1 2026), $2.2 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 34.55 Mn |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 3.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.53 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 982,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 653,000.00 |
| Sep 30, 2023 | 728,000.00 |
| Jun 30, 2023 | 740,000.00 |
| Mar 31, 2023 | 437,000.00 |
| Dec 31, 2022 | 524,000.00 |
| Sep 30, 2022 | 985,000.00 |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 787,000.00 |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 598,000.00 |
| Jun 30, 2021 | 629,000.00 |